Immunogen: GST-fusion peptides of Sup11p were used for polyclonal antibody production in rabbits .
Epitope: Likely targets the N-terminal region (amino acids 1–150), which shows high antigenicity .
Cell Wall Remodeling: Sup11p depletion alters expression of glucanases (e.g., ags1+, bgs1+) and glucan synthases, suggesting a regulatory role .
Stress Response: Sup11p interacts with proteins involved in redox homeostasis (e.g., thioredoxin peroxidase) .
Knockout Phenotype: sup11Δ strains exhibit sensitivity to calcofluor white (cell wall stress agent) .
Overexpression: Induces abnormal cell morphology under high-temperature stress .
Antibody Specificity: No commercial vendors (e.g., Bio-Techne, Sigma-Aldrich) list SPBC1683.04 antibodies, suggesting limited availability .
Cross-Reactivity: Homology with human proteins (e.g., glycosidases) may necessitate validation in heterologous systems .
KEGG: spo:SPBC1683.04
STRING: 4896.SPBC1683.04.1
SPBC1683.04 is a gene located on the left arm of chromosome II in Schizosaccharomyces pombe. According to genomic analysis, it is positioned in proximity to the thi7 gene, with deletion junction analysis pinpointing coordinate 146651 of chromosome II as a critical location in this region . This genomic region appears to be significant in the context of chromosome integrity, as studies have identified it as a site involved in terminal chromosome deletions, potentially making it relevant for investigation of genomic stability mechanisms. The gene's precise location near regions susceptible to chromosomal rearrangements suggests it may have functional significance in maintaining chromosome architecture or responding to DNA damage.
Validating antibody specificity for SPBC1683.04 requires a multi-faceted approach:
Genetic validation: Compare antibody reactivity between wild-type S. pombe and strains with SPBC1683.04 deletions or mutations. Terminal deletion strains affecting this locus, such as DY50490 described in the literature, can serve as negative controls .
Western blot analysis: The antibody should detect a band of the expected molecular weight in wild-type samples but show absence or alteration in mutant samples. Following approaches similar to those used for antibodies like Oligodendrocyte Marker O4, rigorous analysis of band specificity is essential .
Immunoprecipitation-mass spectrometry: Confirm that the immunoprecipitated protein matches SPBC1683.04's predicted sequence.
Competition assays: Preincubation with purified antigen should eliminate specific staining in immunohistochemistry or Western blots.
Cross-reactivity testing: Examine reactivity against related proteins, particularly other genes in the same family that might share epitopes.
For effective immunohistochemical detection of SPBC1683.04 in S. pombe samples:
Fixation optimization: Compare 4% paraformaldehyde (15-20 minutes at room temperature) with cold methanol fixation (-20°C for 6-10 minutes). Based on protocols for other yeast proteins, paraformaldehyde often provides better morphology preservation while methanol may offer superior epitope accessibility .
Permeabilization: Following fixation, permeabilize cells with 0.1-0.5% Triton X-100 or similar detergents to allow antibody access to intracellular antigens. For S. pombe cell walls, enzymatic digestion with zymolyase may be beneficial.
Blocking conditions: Use 3-5% BSA or normal serum (from the same species as the secondary antibody) to reduce non-specific binding. For yeast cells, extended blocking periods (1-2 hours) often improve signal-to-noise ratios.
Antibody dilution series: Test a range of primary antibody concentrations (typically 1-10 μg/mL) to identify the optimal dilution that maximizes specific signal while minimizing background.
Detection systems: Compare direct fluorophore-conjugated secondary antibodies with amplification systems (such as tyramide signal amplification) for low-abundance targets.
To investigate cell cycle-dependent changes in SPBC1683.04 expression and localization:
Synchronization techniques: Employ nitrogen starvation and release or size selection by centrifugal elutriation to obtain S. pombe populations at defined cell cycle stages.
Time-course analysis: Collect samples at regular intervals (typically 15-30 minutes) following synchronization release and process for Western blot analysis with SPBC1683.04 antibodies.
Quantitative immunofluorescence: Fix synchronized cells at different cell cycle points, perform immunostaining with SPBC1683.04 antibodies, and quantify signal intensity changes. Co-staining with established cell cycle markers (such as DNA content with DAPI) can confirm cell cycle positions.
Flow cytometry: For population-level analysis, combine SPBC1683.04 antibody staining with DNA content analysis to correlate expression with cell cycle phase at the single-cell level.
Live-cell imaging: If developing a fluorescently tagged version of SPBC1683.04, validate localization patterns with antibody staining before proceeding with time-lapse microscopy through the cell cycle.
Given the location of SPBC1683.04 near regions involved in terminal deletions , antibodies against this protein can be valuable tools for studying chromosome integrity:
Chromatin immunoprecipitation (ChIP): Use SPBC1683.04 antibodies for ChIP followed by sequencing (ChIP-seq) to map protein binding sites across the genome, particularly at chromosome ends or near deletion-prone regions.
Co-immunoprecipitation analysis: Identify protein interaction partners of SPBC1683.04 that might function in maintaining chromosome integrity. This could reveal connections to pathways involved in various modes of terminal deletion described in the literature, including homology-driven translocation, homology-independent chromosome fusion, and de novo telomere addition .
Immunofluorescence-FISH: Combine antibody staining with fluorescence in situ hybridization to simultaneously visualize SPBC1683.04 localization and specific chromosome regions, potentially revealing associations with telomeres or breakage-prone sites.
DNA damage response: Track SPBC1683.04 localization following induction of DNA damage (using agents like methyl methanesulfonate or hydroxyurea) to determine if the protein responds to or participates in DNA repair processes.
Genetic interaction studies: Compare SPBC1683.04 localization and function in strains with mutations in known chromosome stability genes to establish genetic pathways.
For effective multi-protein co-localization studies involving SPBC1683.04:
Sequential immunostaining: When using multiple primary antibodies from the same species, employ sequential staining with blocking steps between antibody pairs. This approach is particularly useful when cross-reactivity is a concern.
Spectral compatibility: Carefully select fluorophores with minimal spectral overlap for secondary antibodies. For three or more targets, consider fluorophores with narrow emission spectra or use spectral unmixing during image analysis.
Control samples: Prepare single-stained controls for each antibody to assess bleed-through and cross-reactivity. Following protocols established for other antibodies like the Oligodendrocyte Marker O4, include appropriate negative controls .
Fixation optimization: Different fixation methods may preserve co-localization relationships differently. Compare paraformaldehyde, methanol, and combination protocols to determine which best maintains the spatial relationships between SPBC1683.04 and other proteins of interest.
Image acquisition settings: Use identical acquisition parameters across samples and controls. For quantitative co-localization analysis, ensure that signals are within the linear range of detection.
Analysis methods: Employ both qualitative visual assessment and quantitative co-localization metrics (Pearson's correlation, Manders' coefficients) to evaluate spatial relationships objectively.
To investigate SPBC1683.04 responses to cellular stress:
Stress induction: Expose S. pombe cultures to various stressors including:
Oxidative stress (H₂O₂ treatment)
Heat shock (temperature shift to 37-42°C)
DNA damage (UV irradiation, MMS, or hydroxyurea treatment)
Nutrient limitation (glucose or nitrogen deprivation)
Osmotic stress (high salt conditions)
Temporal analysis: Monitor SPBC1683.04 expression, localization, and post-translational modifications at multiple time points after stress induction (typically 15, 30, 60, 120, and 240 minutes).
Subcellular fractionation: Separate nuclear, cytoplasmic, and chromatin-bound fractions to determine if stress alters SPBC1683.04 distribution between cellular compartments.
Phosphorylation state: Use phospho-specific antibodies or phosphatase treatments to assess whether stress conditions trigger phosphorylation changes in SPBC1683.04.
Protein stability: Perform cycloheximide chase experiments to determine if stress affects SPBC1683.04 protein stability or turnover rates.
Given the potential role of the SPBC1683.04 region in chromosome maintenance, as suggested by its involvement in terminal deletion events , stress-induced changes might reveal functions in genome protection mechanisms.
To investigate potential interactions between SPBC1683.04 and telomere maintenance proteins:
Co-immunoprecipitation: Use SPBC1683.04 antibodies to pull down associated proteins, followed by Western blotting for known telomere maintenance factors (e.g., Taz1, Pot1, Rap1).
Reciprocal immunoprecipitation: Perform pull-downs using antibodies against telomere proteins and probe for SPBC1683.04 to confirm interactions from both perspectives.
Proximity ligation assay (PLA): This technique can detect protein-protein interactions in situ with high sensitivity, allowing visualization of interactions between SPBC1683.04 and telomere proteins in their native cellular context.
Bimolecular fluorescence complementation (BiFC): By fusing complementary fragments of a fluorescent protein to SPBC1683.04 and potential telomere protein partners, interactions can be visualized in living cells.
ChIP-reChIP: This sequential ChIP approach can determine if SPBC1683.04 and telomere proteins co-occupy the same DNA regions, particularly at chromosome ends.
The search results suggest a potential role for the SPBC1683.04 region in chromosome terminal maintenance, as it is involved in terminal deletion events and chromosome healing mechanisms such as de novo telomere addition .
For optimal Western blot detection of SPBC1683.04:
| Parameter | Optimization Guidelines | Recommended Conditions |
|---|---|---|
| Sample Preparation | Test multiple lysis methods (TCA precipitation, glass bead mechanical disruption, SDS boiling) | Glass bead lysis in buffer containing protease inhibitors and phosphatase inhibitors |
| Protein Amount | Load titration series to determine optimal loading | 20-50 μg total protein per lane |
| Gel Percentage | Select based on protein size | 10% for proteins 40-100 kDa; 12% for 15-40 kDa |
| Transfer Conditions | Compare wet and semi-dry transfer | Wet transfer at 100V for 1 hour or 30V overnight at 4°C |
| Blocking Agent | Test milk vs. BSA in TBS-T | 5% non-fat dry milk in TBS-T (general starting point) |
| Primary Antibody | Titrate concentration | Start at 1 μg/mL (1:1000 of 1 mg/mL stock) |
| Incubation Time | Compare short vs. long incubation | Overnight at 4°C generally provides best signal-to-noise ratio |
| Detection Method | Compare chemiluminescence vs. fluorescence | Enhanced chemiluminescence for general detection; fluorescence for quantification |
Following approaches similar to those used for other antibodies in research settings, optimization should include both positive controls (wild-type samples) and negative controls (SPBC1683.04 deletion strains) to confirm specificity .
For effective immunoprecipitation of SPBC1683.04 and associated proteins:
Lysis buffer composition: Test different detergent and salt concentrations to optimize extraction while preserving protein-protein interactions. A starting buffer might contain:
50 mM HEPES or Tris-HCl (pH 7.5)
150 mM NaCl (test range from 100-300 mM)
0.5% NP-40 or Triton X-100 (test range 0.1-1%)
1 mM EDTA
Protease inhibitor cocktail
Phosphatase inhibitors if phosphorylation is relevant
Antibody coupling: Compare direct antibody coupling to beads (using crosslinkers) versus indirect capture using Protein A/G beads. Direct coupling can reduce antibody chain interference in downstream applications.
Input-to-antibody ratio: Optimize the ratio of cell lysate to antibody amount. A typical starting point is 5 μg antibody per 1 mg protein lysate.
Incubation conditions: Test different incubation times (2 hours vs. overnight) and temperatures (4°C is standard to preserve interactions).
Wash stringency: Develop a washing protocol that removes background while retaining specific interactions. A typical approach includes 3-5 washes with decreasing detergent concentrations.
Elution methods: Compare different elution strategies (low pH, high pH, peptide competition, boiling in SDS) to identify the most efficient approach for your experimental needs.
For rigorous immunofluorescence studies with SPBC1683.04 antibodies:
Genetic controls:
Antibody controls:
Primary antibody omission (to assess secondary antibody background)
Isotype control (non-specific IgG of the same isotype and species)
Antigen pre-absorption (primary antibody pre-incubated with immunizing peptide)
Sample preparation controls:
Autofluorescence control (untreated cells processed through the entire protocol)
Fixation control (comparison of different fixation methods)
Imaging controls:
Single-channel controls for multi-channel imaging (to assess bleed-through)
Exposure settings matched across all comparative samples
Following protocols similar to those established for other cellular antibodies like Oligodendrocyte Marker O4, these controls ensure that observed signals are specific to SPBC1683.04 and not artifacts of the experimental process .
When encountering issues with SPBC1683.04 antibody staining:
| Problem | Potential Causes | Troubleshooting Strategies |
|---|---|---|
| High Background | Excessive primary antibody concentration | Titrate antibody to lower concentrations (0.1-5 μg/mL range) |
| Insufficient blocking | Increase blocking time (2 hours) or try different blocking agents (BSA, normal serum, commercial blockers) | |
| Inadequate washing | Increase number and duration of washes; add 0.05-0.1% Tween-20 to wash buffers | |
| Cross-reactivity | Use highly cross-absorbed secondary antibodies; pre-absorb with yeast lysates | |
| Fixation artifacts | Compare different fixation protocols (paraformaldehyde vs. methanol) | |
| Weak Signal | Insufficient antibody concentration | Increase primary antibody concentration or incubation time |
| Epitope masking during fixation | Try alternative fixation methods or antigen retrieval techniques | |
| Low protein expression | Consider signal amplification methods (tyramide signal amplification, higher sensitivity detection systems) | |
| Protein degradation | Add additional protease inhibitors during sample preparation | |
| Low antibody affinity | Try different antibody clones or polyclonal alternatives |
When optimizing immunofluorescence protocols, methodically test each variable while keeping others constant to identify the specific factors affecting your results .
Given the involvement of the SPBC1683.04 locus in terminal deletion events , antibodies against this protein can help elucidate underlying mechanisms:
ChIP-seq mapping: Use SPBC1683.04 antibodies to perform genome-wide binding site analysis, focusing on:
Damage response dynamics: Monitor SPBC1683.04 localization before and after inducing DNA damage or replication stress, particularly conditions that promote terminal deletions.
Protein complex identification: Use SPBC1683.04 antibodies for immunoprecipitation followed by mass spectrometry to identify protein complexes that may function in chromosome end protection or repair.
Genetic interaction studies: Compare SPBC1683.04 localization and function in strains with mutations in genes known to be involved in telomere maintenance, DNA repair, or chromosome stability.
Structural analysis: Investigate whether SPBC1683.04 participates in higher-order chromatin structures that protect chromosome ends or prevent inappropriate repair events leading to terminal deletions.
The search results indicate multiple mechanisms for terminal deletion in S. pombe, including a case where "soft-clipped parts of these reads match the sequence of the 28S rDNA gene" near the SPBC1683.04 region , suggesting potential involvement in non-homologous end joining or other repair processes.
Advanced techniques that can be paired with SPBC1683.04 immunoprecipitation include:
ChIP-seq: Identify genome-wide binding sites of SPBC1683.04, particularly at chromosome termini or fragile sites prone to breakage.
RNA immunoprecipitation (RIP): Determine if SPBC1683.04 associates with specific RNAs, potentially including non-coding RNAs involved in chromosome maintenance.
Proximity labeling: Combine SPBC1683.04 antibodies with techniques like BioID or APEX2 to identify proteins in close proximity in living cells, providing a more comprehensive view of the protein's interaction network.
Mass spectrometry analysis of post-translational modifications: Identify how SPBC1683.04 is modified (phosphorylation, ubiquitination, SUMOylation) in response to chromosome stress or during normal cell cycle progression.
DNA-protein interaction mapping: Use techniques like DRIP (DNA-RNA Immunoprecipitation) to investigate if SPBC1683.04 associates with specialized DNA structures like R-loops or G-quadruplexes that might influence chromosome stability.
Single-molecule imaging: Combine immunoprecipitation data with super-resolution microscopy to visualize SPBC1683.04 dynamics at individual chromosome sites.
These approaches could help elucidate SPBC1683.04's potential role in the diverse modes of chromosome terminal deletion observed in S. pombe, including homology-driven translocation, homology-independent chromosome fusion, and de novo telomere addition .